LOVF.F Stock Overview
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Cannara Biotech Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.64 |
52 Week High | CA$0.84 |
52 Week Low | CA$0.49 |
Beta | 1.15 |
1 Month Change | -8.72% |
3 Month Change | 14.43% |
1 Year Change | 16.59% |
3 Year Change | -41.55% |
5 Year Change | -55.22% |
Change since IPO | -64.12% |
Recent News & Updates
Recent updates
Shareholder Returns
LOVF.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 3.0% | -2.2% | -3.7% |
1Y | 16.6% | 11.6% | 20.5% |
Return vs Industry: LOVF.F exceeded the US Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: LOVF.F underperformed the US Market which returned 20.2% over the past year.
Price Volatility
LOVF.F volatility | |
---|---|
LOVF.F Average Weekly Movement | 12.3% |
Pharmaceuticals Industry Average Movement | 9.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LOVF.F has not had significant price volatility in the past 3 months.
Volatility Over Time: LOVF.F's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | n/a | Zohar Krivorot | cannara.ca |
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers.
Cannara Biotech Inc. Fundamentals Summary
LOVF.F fundamental statistics | |
---|---|
Market cap | US$56.08m |
Earnings (TTM) | US$6.56m |
Revenue (TTM) | US$48.12m |
8.7x
P/E Ratio1.2x
P/S RatioIs LOVF.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LOVF.F income statement (TTM) | |
---|---|
Revenue | CA$66.43m |
Cost of Revenue | CA$35.80m |
Gross Profit | CA$30.63m |
Other Expenses | CA$21.58m |
Earnings | CA$9.05m |
Last Reported Earnings
Nov 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.10 |
Gross Margin | 46.11% |
Net Profit Margin | 13.62% |
Debt/Equity Ratio | 58.5% |
How did LOVF.F perform over the long term?
See historical performance and comparison